- | Dec 01 2014 |
In the spirit of #GivingTuesday, a global day dedicated to giving back on December 2, Alliance for Cancer Gene Therapy (ACGT) asks donors to support their favorite causes in the spirit of the holiday season.
Here at ACGT, the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, we’re particularly excited about #GivingTuesday this year, as we’re unveiling our new #NotImmune campaign.
#NotImmune aims to put a spotlight on the need for funding research, so cancer can become a more manageable disease and patients can receive quality treatment with fewer painful side effects.
Cancer is an aggressive disease for which the treatments often come with devastating side effects. Cell and gene therapies, such as immunotherapy treatments for cancer, attack the cancer, not the patient. It’s a powerful message and a game changer for those undergoing cancer treatments. We want to fund research that will bring these types of treatments to all.
#NotImmune is a call to action – an opportunity for people to show family, friends and colleagues that they support breakthrough research, such as immunotherapy treatments, that use the body’s own immune system to attack the cancer while minimizing side effects.
We’re fortunate to have funded researchers early on, selected by our esteemed Scientific Advisory Council, who are now considered pioneers in the fields of cell and gene therapy, and to have an active and engaged community of supporters. Cancer is something that impacts patients, their families and the community and we invite everyone to join us in showing they’re not immune to the cause.
With your support, we help Investigators to uncover breakthrough treatments that make cancer a more manageable disease and allow patients to lead longer and fuller lives.
No one is immune to cancer, no one should be immune to the cause. Attack the cancer, not the patient. One-hundred percent of all donations go directly to research.
Support Cancer Research!
Share your story using #NotImmune and tell us why cancer research matters to you!